-DOCSTART- -X- O
OBJECTIVE -X- _ O
: -X- _ O
Cineole -X- _ B-Intervention
has -X- _ O
mucolytic -X- _ O
, -X- _ O
bronchodilating -X- _ O
and -X- _ O
anti-inflammatory -X- _ O
properties -X- _ O
and -X- _ O
reduces -X- _ O
the -X- _ O
exacerbation -X- _ O
rate -X- _ O
in -X- _ O
patients -X- _ O
suffering -X- _ O
from -X- _ O
COPD -X- _ O
, -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
ameliorates -X- _ O
symptoms -X- _ O
in -X- _ O
patients -X- _ O
suffering -X- _ O
from -X- _ O
asthma -X- _ O
and -X- _ O
rhinosinusitis. -X- _ O
Based -X- _ O
on -X- _ O
these -X- _ O
effects -X- _ O
, -X- _ O
we -X- _ O
therefore -X- _ O
postulated -X- _ O
the -X- _ O
hypothesis -X- _ O
that -X- _ O
patients -X- _ B-Patient
with -X- _ I-Patient
acute -X- _ I-Patient
bronchitis -X- _ I-Patient
would -X- _ O
also -X- _ O
benefit -X- _ O
from -X- _ O
therapy -X- _ O
with -X- _ O
Cineole. -X- _ B-Patient
METHODS -X- _ O
: -X- _ O
As -X- _ O
part -X- _ O
of -X- _ O
a -X- _ O
double-blind -X- _ O
, -X- _ O
placebo-controlled -X- _ O
, -X- _ O
multi-center-study -X- _ O
, -X- _ O
a -X- _ O
total -X- _ O
of -X- _ O
242 -X- _ B-Patient
patients -X- _ I-Patient
with -X- _ I-Patient
confirmed -X- _ I-Patient
acute -X- _ I-Patient
bronchitis -X- _ I-Patient
was -X- _ O
randomly -X- _ O
selected -X- _ O
to -X- _ O
participate. -X- _ O
Over -X- _ O
a -X- _ O
period -X- _ O
of -X- _ O
10 -X- _ O
days -X- _ O
, -X- _ O
all -X- _ O
patients -X- _ O
were -X- _ O
administered -X- _ B-Intervention
3 -X- _ I-Intervention
x -X- _ I-Intervention
200 -X- _ I-Intervention
mg -X- _ I-Intervention
of -X- _ I-Intervention
Cineole -X- _ I-Intervention
, -X- _ O
or -X- _ O
a -X- _ O
respective -X- _ B-Comparison
placebo -X- _ I-Comparison
, -X- _ O
per -X- _ O
day. -X- _ O
The -X- _ O
primary -X- _ O
outcome -X- _ O
measure -X- _ O
was -X- _ O
a -X- _ O
Bronchitis -X- _ O
Sum -X- _ O
Score -X- _ O
, -X- _ O
which -X- _ O
summarises -X- _ O
the -X- _ O
relevant -X- _ O
symptoms -X- _ O
of -X- _ O
acute -X- _ O
bronchitis. -X- _ O
RESULTS -X- _ O
: -X- _ O
After -X- _ O
4 -X- _ O
days -X- _ O
of -X- _ O
treatment -X- _ O
it -X- _ O
was -X- _ O
notable -X- _ O
, -X- _ O
that -X- _ O
the -X- _ O
patient -X- _ B-Outcome
group -X- _ I-Outcome
treated -X- _ I-Outcome
with -X- _ I-Outcome
Cineole -X- _ I-Outcome
, -X- _ I-Outcome
showed -X- _ I-Outcome
significantly -X- _ I-Outcome
more -X- _ I-Outcome
improvements -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
bronchitis-sum-score -X- _ I-Outcome
than -X- _ I-Outcome
those -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
placebo -X- _ I-Outcome
group -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.0383 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
The -X- _ I-Outcome
statistical -X- _ I-Outcome
significant -X- _ I-Outcome
difference -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
individual -X- _ I-Outcome
outcome -X- _ I-Outcome
measures -X- _ I-Outcome
was -X- _ I-Outcome
especially -X- _ I-Outcome
underlined -X- _ I-Outcome
by -X- _ I-Outcome
the -X- _ I-Outcome
frequency -X- _ I-Outcome
of -X- _ I-Outcome
cough -X- _ I-Outcome
fits -X- _ I-Outcome
by -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.0001 -X- _ I-Outcome
after -X- _ I-Outcome
4 -X- _ I-Outcome
days. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
The -X- _ O
effects -X- _ B-Outcome
of -X- _ I-Outcome
Cineole -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
treatment -X- _ I-Outcome
of -X- _ I-Outcome
acute -X- _ I-Outcome
bronchitis -X- _ I-Outcome
were -X- _ I-Outcome
clearly -X- _ I-Outcome
measurable -X- _ I-Outcome
and -X- _ I-Outcome
could -X- _ I-Outcome
be -X- _ I-Outcome
proven -X- _ I-Outcome
after -X- _ I-Outcome
a -X- _ I-Outcome
treatment -X- _ I-Outcome
period -X- _ I-Outcome
of -X- _ I-Outcome
merely -X- _ I-Outcome
4 -X- _ I-Outcome
days. -X- _ I-Outcome
This -X- _ I-Outcome
study -X- _ I-Outcome
corroborates -X- _ I-Outcome
the -X- _ I-Outcome
fact -X- _ I-Outcome
that -X- _ I-Outcome
Cineole -X- _ I-Outcome
actively -X- _ I-Outcome
and -X- _ I-Outcome
significantly -X- _ I-Outcome
reduces -X- _ I-Outcome
cough -X- _ I-Outcome
frequency -X- _ I-Outcome
after -X- _ I-Outcome
four -X- _ I-Outcome
days. -X- _ I-Outcome
Therefore -X- _ I-Outcome
it -X- _ I-Outcome
has -X- _ I-Outcome
been -X- _ I-Outcome
shown -X- _ I-Outcome
to -X- _ I-Outcome
have -X- _ I-Outcome
a -X- _ I-Outcome
great -X- _ I-Outcome
socioeconomic -X- _ I-Outcome
impact. -X- _ I-Outcome
TRIAL -X- _ O
REGISTRATION -X- _ O
: -X- _ O
ISRCTN -X- _ O
: -X- _ O
ISRCTN37784439 -X- _ O

